XML 19 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statement of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net income/(loss) attributable to the Company $ 9,505 $ (149)
Adjustments to arrive at net income from continuing operations [Abstract]    
Net income attributable to noncontrolling interests 793 747
Net (income)/loss from discontinued operations (1,554) (1,663)
Net income/(loss) from continuing operations 8,744 (1,065)
Adjustments to reconcile net income/(loss) from continuing operations to net cash provided by/(used in) operating activities:    
Depreciation and amortization 4,960 4,765
Net income attributable to noncontrolling interests (793) (747)
Equity issued as compensation 1,927 1,469
Provision for loan losses 4,000 13,350
Loans originated for sale (34,218) (22,665)
Proceeds from sale of loans held for sale 42,981 27,838
Gain on the repurchase of debt (879) 0
Deferred Income Tax Expense (Benefit) (674) (1,801)
Net decrease/(increase) in other operating activities (9,296) (20,214)
Net cash provided by/(used in) operating activities of continuing operations 18,100 4,532
Net cash provided by/(used in) operating activities of discontinued operations 1,090 1,642
Net cash provided by/(used in) operating activities 19,190 6,174
Investment securities available for sale:    
Purchases (102,353) (195,874)
Sales 4,359 82,102
Maturities, redemptions, and principal payments 115,079 121,177
(Investments)/distributions in trusts, net (591) (336)
(Purchase)/ redemption of Federal Home Loan Banks stock 1,075 521
Net (increase)/ decrease in portfolio loans (200,414) 8,910
Proceeds from sale of OREO 1,176 4,861
Proceeds from sale and repayments of non-strategic loan portfolio 0 1,000
Capital expenditures, net of sale proceeds (1,864) (1,263)
Cash received from dispositions/ (paid for acquisitions, including deferred acquisition obligations, net of cash acquired) 0 2,752
Net Cash provided by/ (used in) investing activities of continuing operations (183,533) 23,850
Net cash provided by/ (used in) investing activities of discontinued operations (21) 0
Net cash provided by/(used in) investing activities (183,554) 23,850
Cash flows from financing activities:    
Net increase in deposits 72,040 53,464
Net (decrease)/increase in securities sold under agreements to repurchase and other (22,240) (131,320)
Net (decrease)/increase in short-term Federal Home Loan Bank borrowings 70,000 (10,000)
Advances of long-term Federal Home Loan Bank borrowings 15,000 15,000
Repayments of long-term Federal Home Loan Bank borrowings (24,276) (85,868)
Repurchase of debt (2,420) 0
Dividends paid to common stockholders (776) (761)
Dividends paid to preferred stockholders (73) (73)
Repurchase of warrants (15,000) 0
Tax deficiency from certain stock compensation awards (952) (1,221)
Proceeds from stock option exercises 184 80
Proceeds from issuance of common stock, net 557 591
Other equity adjustments 102 (620)
Net Cash Provided by (Used in) Financing Activities, Continuing Operations 92,146 (160,728)
Cash Provided by (Used in) Financing Activities, Discontinued Operations 0 0
Net Cash Provided by (Used in) Financing Activities 92,146 (160,728)
Net increase/(decrease) in cash and cash equivalents (72,218) (130,704)
Cash and cash equivalents at beginning of year 203,354 494,433
Cash and cash equivalents at end of period 131,136 363,729
Supplementary schedule of non-cash investing and financing activities:    
Cash paid for interest 11,165 13,623
Cash paid for income taxes, net of (refunds received) 996 13,605
Change in unrealized gain/ (loss) on securities available for sale, net of tax 2 (831)
Change in unrealized gain/ (loss) on cash flow hedges, net of tax 81 416
Change in unrealized gain/ (loss) on other, net of tax (141) 42
Held to maturity investments transferred to available for sale or other investments at amortized cost 0 500
Loans transferred into other real estate owned from held for sale or portfolio 0 3,311
Loans transferred into/(out of) held for sale from/(to) portfolio 0 (526)
Equity issued for acquisitions, including deferred acquisition obligations $ 0 $ 4,290